C
Chun Li
Researcher at Beijing University of Chinese Medicine
Publications - 35
Citations - 1184
Chun Li is an academic researcher from Beijing University of Chinese Medicine. The author has contributed to research in topics: Heart failure & Blood stasis. The author has an hindex of 15, co-authored 32 publications receiving 766 citations. Previous affiliations of Chun Li include Peking University.
Papers
More filters
Journal ArticleDOI
BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine
Zhongyang Liu,Feifei Guo,Yong Wang,Chun Li,Xinlei Zhang,Honglei Li,Lihong Diao,Jiangyong Gu,Wei Wang,Dong Li,Fuchu He +10 more
TL;DR: BATMAN-TCM will contribute to the understanding of the “multi-component, multi-target and multi-pathway” combinational therapeutic mechanism of TCM, and provide valuable clues for subsequent experimental validation, accelerating the elucidation of TCm’s molecular mechanism.
Journal ArticleDOI
A Review of Chinese Herbal Medicine for the Treatment of Chronic Heart Failure.
TL;DR: The frequently used Chinese herbs, formulae and patent Chinese drugs in treating patients with heart failure and published clinical evaluations of Chinese herbs in treating cardiovascular diseases are summarized and mechanisms by which Chinese herbs exert cardio-protective effects are reviewed.
Journal ArticleDOI
VEGF stimulated the angiogenesis by promoting the mitochondrial functions
TL;DR: It is shown that VEGF significantly stimulated the proliferation, migration and cell cycle of endothelial cells, and it also induced tube formation in vitro significantly, and evidence for mitochondria as new therapeutic target of V EGF signaling in the angiogenic vascular disorders is provided.
Journal ArticleDOI
Phytochemical and pharmacological progress on the genus Syringa
TL;DR: This study reviews phytochemical and pharmacological progress on Syringa in the recent 20 years and discusses the future research prospects to provide a reference in further promotion and application of the genus.
Journal ArticleDOI
Qishenyiqi Protects Ligation-Induced Left Ventricular Remodeling by Attenuating Inflammation and Fibrosis via STAT3 and NF-κB Signaling Pathway
TL;DR: This study demonstrated that QSYQ protected LAD ligation-induced left VR via attenuating AngII -NADPH oxidase pathway and inhabiting inflammation, which further proves the beneficial effects of Q SYQ.